| Purinergic signaling in the immune system F Di Virgilio, M Vuerich Autonomic Neuroscience 191, 117-123, 2015 | 247 | 2015 |
| ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment G Bianchi, M Vuerich, P Pellegatti, D Marimpietri, L Emionite, I Marigo, ... Cell death & disease 5 (3), e1135-e1135, 2014 | 124 | 2014 |
| Deletion of lactate dehydrogenase-A in myeloid cells triggers antitumor immunity P Seth, E Csizmadia, A Hedblom, M Vuerich, H Xie, M Li, MS Longhi, ... Cancer research 77 (13), 3632-3643, 2017 | 120 | 2017 |
| Metabolic switch in the tumor microenvironment determines immune responses to anti-cancer therapy B Wegiel, M Vuerich, S Daneshmandi, P Seth Frontiers in oncology 8, 284, 2018 | 105 | 2018 |
| IL‐18 associates to microvesicles shed from human macrophages by a LPS/TLR‐4 independent mechanism in response to P2X receptor stimulation S Gulinelli, E Salaro, M Vuerich, D Bozzato, C Pizzirani, G Bolognesi, ... European journal of immunology 42 (12), 3334-3345, 2012 | 98 | 2012 |
| Bilirubin suppresses Th17 immunity in colitis by upregulating CD39 MS Longhi, M Vuerich, A Kalbasi, JE Kenison, A Yeste, E Csizmadia, ... JCI insight 2 (9), 2017 | 86 | 2017 |
| Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis M Vuerich, R Harshe, LA Frank, S Mukherjee, B Gromova, E Csizmadia, ... Journal of hepatology 74 (1), 48-57, 2021 | 47 | 2021 |
| Ectonucleotidases in intestinal and hepatic inflammation M Vuerich, SC Robson, MS Longhi Frontiers in immunology 10, 507, 2019 | 45 | 2019 |
| Control of gut inflammation by modulation of purinergic signaling M Vuerich, S Mukherjee, SC Robson, MS Longhi Frontiers in immunology 11, 1882, 2020 | 27 | 2020 |
| Dysfunctional immune regulation in autoimmune hepatitis: from pathogenesis to novel therapies M Vuerich, N Wang, A Kalbasi, JJ Graham, MS Longhi Frontiers in Immunology 12, 746436, 2021 | 23 | 2021 |
| Endogenous antisense RNA curbs CD39 expression in Crohn’s disease RP Harshe, A Xie, M Vuerich, LA Frank, B Gromova, H Zhang, RJ Robles, ... Nature communications 11 (1), 5894, 2020 | 22 | 2020 |
| Modulation of CD39 and exogenous APT102 correct immune dysfunction in experimental colitis and Crohn’s disease RJ Robles, S Mukherjee, M Vuerich, A Xie, R Harshe, PJ Cowan, ... Journal of Crohn's and Colitis 14 (6), 818-830, 2020 | 22 | 2020 |
| Dysregulation of adenosinergic signaling in systemic and organ-specific autoimmunity M Vuerich, RP Harshe, SC Robson, MS Longhi International Journal of Molecular Sciences 20 (3), 528, 2019 | 20 | 2019 |
| Eosinophils and purinergic signaling in health and disease D Ferrari, M Vuerich, F Casciano, MS Longhi, E Melloni, P Secchiero, ... Frontiers in Immunology 11, 1339, 2020 | 15 | 2020 |
| Limited TCR repertoire and ENTPD1 dysregulation mark late-stage COVID-19 N Wang, M Vuerich, A Kalbasi, JJ Graham, E Csizmadia, ZJ Manickas-Hill, ... IScience 24 (10), 2021 | 9 | 2021 |
| Blockade of PGK1 and ALDOA enhances bilirubin control of Th17 cells in Crohn’s disease M Vuerich, N Wang, JJ Graham, L Gao, W Zhang, A Kalbasi, L Zhang, ... Communications Biology 5 (1), 994, 2022 | 7 | 2022 |
| Endogenous antisense RNA and dysregulation of CD39 expression in inflammatory bowel disease MS Longhi, R Harshe, A Xie, H Zhang, RJ Robles, S Mukherjee, ... The Journal of Immunology 202 (1_Supplement), 182.10-182.10, 2019 | 3 | 2019 |
| Aberrant CD39 levels and regulation mark COVID-19 late stage MS Longhi, N Wang, A Kalbasi, M Vuerich, ZJ Manickas-Hill, J Hecht, ... The Journal of Immunology 206 (1_Supplement), 62.02-62.02, 2021 | 1 | 2021 |
| P2X7R: pivotal player in sepsis-induced liver damage M Vuerich Purinergic Signalling 16 (4), 473-474, 2020 | 1 | 2020 |
| Adenosine-mediated immune responses in inflammatory bowel disease M Vuerich, DH Nguyen, D Ferrari, MS Longhi Frontiers in Cell and Developmental Biology 12, 1429736, 2024 | | 2024 |
